by Markéta Salačová | 15. 12. 2020
[18F] -fluorocholin A radiopharmaceutical, a medicinal product intended for PET/CT examination and diagnosis in the early stages of prostate cancer. The clinical trial of [18F]-fluorocholine inj was initiated and implemented by CZECRIN in collaboration with the Phase...
by Markéta Salačová | 10. 12. 2020
Recombinant protein FGF2-STAB® is a stabilized growth factor developed by Masaryk University in collaboration with its spin-off company Enantis. FGF2-STAB® is a molecule improved by protein engineering and has a prolonged biological effect compared to the native form...
